Resistance to Dolutegravir-A Chink in the Armor?

被引：5
|
作者：
Kuritzkes, Daniel R. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2018年 / 218卷 / 05期
关键词：
ANTIRETROVIRAL-NAIVE ADULTS; STRAND TRANSFER INHIBITOR; ONCE-DAILY DOLUTEGRAVIR; NON-INFERIORITY TRIAL; HIV-1; INFECTION; DOUBLE-BLIND; INITIAL TREATMENT; RALTEGRAVIR; EFFICACY; INTEGRASE;
D O I：
10.1093/infdis/jiy186
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：673 / 675
页数：3
相关论文
共 50 条
  • [31] LAST CHINK IN THEIR ARMOR - METAPHORS OF BRITISH PRIME MINISTERS FROM LLOYDGEORGE TO WILSON,HAROLD
    HUDSON, K
    ENCOUNTER, 1976, 46 (03): : 25 - 35
  • [32] Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses
    Mirko Cortese
    Christopher J. Neufeldt
    Signal Transduction and Targeted Therapy, 6
  • [33] Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses
    Cortese, Mirko
    Neufeldt, Christopher J.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [34] High-level Dolutegravir Resistance Selection on Dolutegravir/Lamivudine
    Llibre, Josep M.
    Jou, Antoni
    Puig, Teresa
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1540 - 1541
  • [35] A new chink in cancer's armor: Unleashing cell death by selective PP5 inhibition
    van Oosten-Hawle, Patricija
    CELL CHEMICAL BIOLOGY, 2023, 30 (10) : 1186 - 1188
  • [36] But what does it mean? + Turgid, arcane writing is the most vulnerable chink in an architect's professional armor
    Kliment, SA
    ARCHITECTURE, 1996, 85 (11): : 71 - &
  • [37] Dolutegravir/abacavir/dolutegravir/lamivudineDrug resistance: 2 case reports
    Reactions Weekly, 2018, 1727 (1) : 118 - 118
  • [38] Genetic Barrier to Resistance for Dolutegravir
    Llibre, Josep M.
    Pulido, Federico
    Garcia, Federico
    Garcia Deltoro, Miguel
    Blanco, Jose L.
    Delgado, Rafael
    AIDS REVIEWS, 2015, 17 (01) : 56 - 64
  • [39] Insights in Dolutegravir-Resistance Pathways
    Mesplede, Thibault
    Gantner, Pierre
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (06) : 1541 - 1542
  • [40] Dolutegravir Resistance and Failure in a Kenyan Patient
    Achieng, Loice
    Riedel, David J.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (01): : 165 - 167
12345